2015 Article in Respiratory Care Discusses Opportunities
Jun 29, 2022 7:20:00 GMT -5
sla55 and MnkdWASmyRtrmntPlan like this
Post by Chris-C on Jun 29, 2022 7:20:00 GMT -5
This paper on inhalation therapy opportunities is a bit dated but I came across it and was curious to see if it mentioned Afrezza. It does. It also mentions a company I had forgotten about, Dance biopharma also developing an inhaled wet aerosol insulin. They announced successful results for a 24 subject study in 2019 but have gone silent since.
Anybody have an update on them?
With respect to the article below, it identifies potential new opportunities. Not as though we need more. We just need to show profit and demonstrate we can sell the products we have approved. Who would have thought that 8 years after approval we would still be under 1K scripts per week? Anyway, happy reading
Aerosolized Medications for Gene and Peptide Therapy
Beth L Laube
Respiratory Care June 2015, 60 (6) 806-824; DOI:
doi.org/10.4187/respcare.03554
Anybody have an update on them?
With respect to the article below, it identifies potential new opportunities. Not as though we need more. We just need to show profit and demonstrate we can sell the products we have approved. Who would have thought that 8 years after approval we would still be under 1K scripts per week? Anyway, happy reading
Aerosolized Medications for Gene and Peptide Therapy
Beth L Laube
Respiratory Care June 2015, 60 (6) 806-824; DOI:
doi.org/10.4187/respcare.03554